Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, October 31, 2014 12:31:32 AM
bullish
falling wedge scan
http://stockcharts.com/school/doku.php?id=chart_school:chart_analysis:chart_patterns:falling_wedge_reversal
$HAE recent news/filings
## source: finance.yahoo.com
Thu, 30 Oct 2014 21:15:46 GMT ~ Is Haemonetics (HAE) Poised to Beat on Q2 Earnings?
read full: http://finance.yahoo.com/news/haemonetics-hae-poised-beat-q2-211546126.html
*********************************************************
Tue, 21 Oct 2014 12:49:00 GMT ~ 3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics’ Donor Management System
[Business Wire] - 3PEA International, Inc. , a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications, today announced that 3PEA and Haemonetics Corporation have entered into an agreement whereby 3PEA International will integrate its PaySign® Connect prepaid debit card solution with Haemonetics’ Donor Management System .
read full: http://finance.yahoo.com/news/3pea-international-haemonetics-partner-integrate-124900553.html
*********************************************************
Mon, 06 Oct 2014 20:00:00 GMT ~ Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014
[PR Newswire] - BRAINTREE, Mass., Oct. 6, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the second quarter of its fiscal year 2015 on November 3, 2014 in a pre-market press release. ...
read full: http://finance.yahoo.com/news/haemonetics-sets-date-second-quarter-200000525.html
*********************************************************
Fri, 03 Oct 2014 19:45:02 GMT ~ Perrigo Sells Some Assets to Imago Pharmaceuticals
read full: http://finance.yahoo.com/news/perrigo-sells-assets-imago-pharmaceuticals-194502187.html
*********************************************************
Tue, 23 Sep 2014 13:30:00 GMT ~ Data Intensity Fortifies Track Record of Success in Oracle EBS R12 Implementations and Upgrades
[PR Newswire] - BEDFORD, Mass., Sept. 23, 2014 /PRNewswire/ -- Data Intensity, the industry leader in managed and cloud services for Oracle technologies and applications, today announced a significant milestone in the company's rich history of driving implementations and upgrades to Oracle E-Business Suite (EBS) Release 12 (R12) for its global customers. Data Intensity is celebrating the inception of its dedicated application engineering team, established five years ago this month to address the market need for expertise in planning, managing and executing on the most complex Oracle projects. This deployment was one of ten R12 projects Data Intensity has delivered successfully this year, and the most recent of the 70+ R12-focused engagements the team has completed since the technology's release in 2007.
read full: http://finance.yahoo.com/news/data-intensity-fortifies-track-record-133000706.html
*********************************************************
$HAE charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$HAE company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/HAE/company-info
Ticker: $HAE
OTC Market Place: Not Available
CIK code: 0000313143
Company name: Haemonetics Corp.
Incorporated In: MA, USA
$HAE share structure
## source: otcmarkets.com
Market Value: $1,976,972,275 a/o Oct 30, 2014
Shares Outstanding: 51,430,080 a/o Jun 28, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$HAE extra dd links
Company name: Haemonetics Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/HAE/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/HAE/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=HAE+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=HAE+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=HAE+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/HAE/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/HAE/news - http://finance.yahoo.com/q/h?s=HAE+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/HAE/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/HAE/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/HAE/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/HAE/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/HAE/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/HAE/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/HAE/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/HAE/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=HAE+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/HAE
DTCC (dtcc.com): http://search2.dtcc.com/?q=Haemonetics+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Haemonetics+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Haemonetics+Corp.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/HAE/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/HAE
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/HAE/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/HAE/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/HAE/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000313143&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/HAE/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/HAE/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/HAE/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/HAE/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=HAE&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=HAE
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/HAE/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=HAE+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=HAE+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=HAE
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=HAE
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=HAE+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/HAE/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=HAE+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/HAE.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=HAE
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/HAE/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/HAE/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/HAE/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/HAE/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/HAE
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/HAE
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/HAE:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=HAE
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=HAE
$HAE DD Notes ~ http://www.ddnotesmaker.com/HAE
Recent HAE News
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 • PR Newswire (US) • 04/10/2024 08:58:00 PM
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge • PR Newswire (US) • 04/04/2024 10:30:00 AM
- Haemonetics Corporation Completes Acquisition of Attune Medical • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:10:30 AM
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical • PR Newswire (US) • 03/05/2024 11:00:00 AM
- Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference • PR Newswire (US) • 02/21/2024 10:57:00 PM
- Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day • PR Newswire (US) • 02/21/2024 10:55:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 08:28:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:49:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:21:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 11:06:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:05:21 AM
- Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website • PR Newswire (US) • 02/08/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:13:59 PM
- Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 • PR Newswire (US) • 01/11/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 11:09:57 AM
- Haemonetics Corporation Completes Acquisition of OpSens Inc. • PR Newswire (US) • 12/12/2023 11:00:00 AM
- Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/07/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:36:29 PM
- OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS • PR Newswire (Canada) • 11/02/2023 11:00:00 AM
- OPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE CIRCULAIRE DE SOLLICITATION DE PROCURATIONS RELATIVEMENT À L'ASSEMBLÉE EXTRAORDINAIRE DES ACTIONNAIRES • PR Newswire (Canada) • 11/02/2023 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 10:19:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 10:16:26 AM
- Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website • PR Newswire (US) • 11/02/2023 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 08:27:01 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM